ATLAS ACS-2, TIMI 51 - Wiki Journal Club
Clinical Question In patients with recent ACS, does the addition of rivaroxaban to standard dual antiplatelet therapy improve CV morbidity and mortality? Bottom Line In patients with recent ACS, the addition of rivaroxaban to standard dual antiplatelet th...